Aardvark Therapeutics
San Diego based pharmaceutical company specializing in gut brain interaction with a focus of inflammation and metabolism
Aardvark Therapeutics
Aardvark Therapeutics develops small-molecule therapies targeting hunger to treat metabolic diseases and obesity.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Novel small molecule programs targeting gut hormones
Drug product manufacturing technologies
Oral delivery technologies
Fixed-dose combination technologies
Service Requirements
Regulatory affairs and quality services
Medical affairs
Sales and marketing consulting
Infrastructure Requirements
cGMP compliant drug product manufacturing facilities
Oral drug delivery manufacturing and distribution infrastructure
Talent Requirements
Experts in small molecule drug development
Clinical trial specialists
Regulatory affairs professionals
Manufacturing and formulation experts
AI Insights
Growth Trajectory
With clinical trials underway and a focus on expanding into the broader obesity market, Aardvark Therapeutics shows strong growth potential.
Market Opportunity
Aardvark has a strong market opportunity by addressing the unmet needs in hyperphagia and obesity care through gut-localized hormone modulation.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats